Sleep and Stroke Rehabilitation Study
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Excessive Daytime Sleepiness
Related studies linked through entity extraction aliases.
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
- Status
- RECRUITING
- Phase
- PHASE1
Characterization of Children with Complaints of Excessive Daytime Sleepiness
- Status
- COMPLETED
- Phase
- N/A
Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal
- Status
- RECRUITING
- Phase
- NA
SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study
- Status
- RECRUITING
- Phase
- N/A
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Bright Light Therapy on Prader-Willi Syndrome
- Status
- RECRUITING
- Phase
- NA
Alternative Epworth Sleepiness Scale ESS-ALT in French
- Status
- COMPLETED
- Phase
- N/A
A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
- Status
- COMPLETED
- Phase
- PHASE3
Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
- Status
- COMPLETED
- Phase
- PHASE2
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
- Status
- COMPLETED
- Phase
- PHASE4
BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness
- Status
- COMPLETED
- Phase
- PHASE2
Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
- Status
- WITHDRAWN
- Phase
- PHASE3
Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA
- Status
- COMPLETED
- Phase
- PHASE3
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
- Status
- COMPLETED
- Phase
- PHASE3
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
- Status
- COMPLETED
- Phase
- PHASE3